Cargando…
Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice
Atypical hemolytic uremic syndrome (aHUS) is frequently associated in humans with loss-of-function mutations in complement-regulating proteins or gain-of-function mutations in complement-activating proteins. Thus, aHUS provides an archetypal complement-mediated disease with which to model new therap...
Autores principales: | Smith-Jackson, Kate, Yang, Yi, Denton, Harriet, Pappworth, Isabel Y., Cooke, Katie, Barlow, Paul N., Atkinson, John P., Liszewski, M. Kathryn, Pickering, Matthew C., Kavanagh, David, Cook, H. Terence, Marchbank, Kevin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391106/ https://www.ncbi.nlm.nih.gov/pubmed/30714990 http://dx.doi.org/10.1172/JCI99296 |
Ejemplares similares
-
Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study
por: Brocklebank, Vicky, et al.
Publicado: (2023) -
Atypical Hemolytic Uremic Syndrome
por: Kavanagh, David, et al.
Publicado: (2013) -
Complement and the atypical hemolytic uremic syndrome in children
por: Loirat, Chantal, et al.
Publicado: (2008) -
Postoperative Atypical Hemolytic Uremic Syndrome Associated with Complement C3 Mutation
por: Matsukuma, Eiji, et al.
Publicado: (2014) -
Efficacy of Eculizumab in Coexisting Complement C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome
por: Busutti, Marco, et al.
Publicado: (2020)